Global uptake of essential cancer medicines with and without complex genomic diagnostics: a retrospective observational study

Kerstin Noelle Vokinger, Simon Hediger, Raffaella Casolino, Dario Trapani, Elisabeth G E de Vries

Open source

DOI
10.1016/s1470-2045(26)00432-8
Published
2026-09
Container
The Lancet Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-26-00432-8,
  title = {Global uptake of essential cancer medicines with and without complex genomic diagnostics: a retrospective observational study},
  author = {Kerstin Noelle Vokinger and Simon Hediger and Raffaella Casolino and Dario Trapani and Elisabeth G E de Vries},
  year = {2026},
  journal = {The Lancet Oncology},
  doi = {10.1016/s1470-2045(26)00432-8},
  url = {https://doi.org/10.1016/s1470-2045(26)00432-8}
}

RIS

TY  - JOUR
TI  - Global uptake of essential cancer medicines with and without complex genomic diagnostics: a retrospective observational study
AU  - Kerstin Noelle Vokinger
AU  - Simon Hediger
AU  - Raffaella Casolino
AU  - Dario Trapani
AU  - Elisabeth G E de Vries
PY  - 2026
JO  - The Lancet Oncology
DO  - 10.1016/s1470-2045(26)00432-8
UR  - https://doi.org/10.1016/s1470-2045(26)00432-8
ER  - 

APA

Vokinger, K. N., Hediger, S., Casolino, R., Trapani, D., & Vries, E. G. E. D. (2026). Global uptake of essential cancer medicines with and without complex genomic diagnostics: a retrospective observational study. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(26)00432-8

Source records